
Alkem Laboratories Investor Relations Material
Latest events

Q1 25/26
Alkem Laboratories
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Alkem Laboratories Limited
Access all reports
Alkem Laboratories Limited is a pharmaceutical company engaged in the development, manufacturing, and marketing of generic and branded medicines. The company’s product portfolio spans multiple therapeutic areas, including anti-infectives, gastroenterology, cardiology, neurology, and pain management. It operates a network of research and manufacturing facilities to supply domestic and international markets. The company is headquartered in Mumbai, India, and its shares are listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE).
Key slides for Alkem Laboratories Limited


Q4 24/25
Alkem Laboratories Limited


Q1 25/26
Alkem Laboratories Limited
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
ALKEM
Country
🇮🇳 India